AndrewMichaelKazMD
Gastroenterology • Seattle, WAAssociate Professor, Medicine, University of Washington School of Medicine
Dr. Kaz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1660 S. Columbian Way
S-111-Gastro
Seattle, WA 98108Phone+1 206-764-2285
Education & Training
University of WashingtonFellowship, Gastroenterology, 2003 - 2007
University of MichiganResidency, Internal Medicine, 1999 - 2002
Duke University School of MedicineClass of 1999
Certifications & Licensure
WA State Medical License 2003 - 2026
MI State Medical License 1999 - 2006- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Start of enrollment: 2012 Apr 30
- A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors Start of enrollment: 2012 Aug 13
- Optimal Treatment for Recurrent Clostridium Difficile Start of enrollment: 2015 Dec 21
Publications & Presentations
PubMed
- 229 citationsEpigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer.William M. Grady, Rachael K. Parkin, Patrick S. Mitchell, Jun Ho Lee, Young Ho Kim
Oncogene. 2008-06-19 - 78 citationsEpigenetic biomarkers in esophageal cancer.Andrew M. Kaz, William M. Grady
Cancer Letters. 2014-01-28 - 130 citationsRandomized Trial of Medical versus Surgical Treatment for Refractory HeartburnStuart Jon Spechler, John G. Hunter, Karen M. Jones, Robert H. Lee, Brian R Smith
The New England Journal of Medicine. 2019-10-16
Press Mentions
Novel Barrett’s Esophagus Screening Assays Based on Swallowable Devices: Will They Change the Game?April 1st, 2019
Grant Support
- Methylated DNA Biomarkers For Barrett'S Esophagus And Esophageal AdenocarcinomaNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
